Display Settings:

Format

Send to:

Choose Destination

    Am J Cardiol. 2004 May 15;93(10):1318-9.

    Validation of the i-STAT handheld activated clotting time for use with bivalirudin.

    Schussler JM, Lander SR, Wissinger LA, Anwar A, Donsky MS, Johnson KB, Vallabhan RC, Wischmeyer JB.

    Department of Cardiology, Baylor University Medical Center, 621 N. Hall Street, Suite 500, Dallas, TX 75226, USA. JeffreSc@baylorhealth.edu

    Bivalirudin is being used more frequently as an anticoagulant in the cardiac catheterization laboratory. Newer devices, used to measure activated clotting time (ACT), have not been thoroughly tested for use with bivalirudin. One such device, the i-STAT ACT, measures the generation of activated thrombin to determine the level of anticoagulation. Our study demonstrated a high level of agreement between the i-STAT ACT and the Hemochron ACT in patients anticoagulated with bivalirudin. In addition, the i-STAT was shown to have an extremely high degree of reproducibility.

    PMID: 15135717 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read